A cause of dilated cardiomyopathy in child: Primary carnitine deficiency;Une cause de cardiomyopathie dilatée chez l'enfant : Le déficit primaire en carnitine

Annales de Cardiologie et d'Angeiologie

Volumn 63, Issue 2, 2014, Pages 107-110

  Baragou, S ^a   Pio, M ^a   Di Bernardo, S ^b   Ksontini, T Boulos ^b   Dommange, S Jiekak ^b   Bonafe, L ^b   Meijboom, E ^b   Sekarski, N ^b  

^a Service de cardiologie   (Togo)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Cardiomyopathy; Carnitine; Fatty acid oxydation

Indexed keywords

CARNITINE; BIOLOGICAL MARKER; ORGANIC CATION TRANSPORTER; SLC22A5 PROTEIN, HUMAN; VITAMIN B COMPLEX;

ARTICLE; BLOOD LEVEL; CARDIOMEGALY; CARNITINE DEFICIENCY; CASE REPORT; CHILD; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; DYSPNEA; ECG ABNORMALITY; ELECTROCARDIOGRAM; GENE; HEART DILATATION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MURMUR; HUMAN; LIFESPAN; MALE; MITRAL VALVE REGURGITATION; MUSCLE HYPOTONIA; MUTATIONAL ANALYSIS; PHYSICAL EXAMINATION; PRESCHOOL CHILD; SINUS RHYTHM; SLC22A5 GENE; SYSTOLIC DYSFUNCTION; T WAVE; THORAX RADIOGRAPHY; TREATMENT DURATION; BLOOD; CARDIOMYOPATHIES; CARDIOMYOPATHY, DILATED; COMPLICATION; DEFICIENCY; GENETICS; HYPERAMMONEMIA; MUSCULAR DISEASES; MUTATION; PROGNOSIS; TIME; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; CARDIOMYOPATHIES; CARDIOMYOPATHY, DILATED; CARNITINE; CHILD, PRESCHOOL; DYSPNEA; HUMANS; HYPERAMMONEMIA; MALE; MUSCULAR DISEASES; MUTATION; ORGANIC CATION TRANSPORT PROTEINS; PROGNOSIS; TIME FACTORS; TREATMENT OUTCOME; VITAMIN B COMPLEX;

EID: 84899493719     PISSN: 00033928     EISSN: 17683181     Source Type: Journal    
DOI: 10.1016/j.ancard.2011.12.006     Document Type: Article

References (12)

1. Amat di Sanfilipo C., Taylor M.R.G., Mestroni L., Botto L.D., Longo N. Cardiomyopathy and carnitine deficiency. Mol Gen Metab 2008, 94:162-166.
2. Erguven M., Yilmaz O., Koc S., Caki S., Ayhan Y., Donmez M., Dolunay G. A case of early diagnosed carnitine deficiency presenting with respiratory symptoms. Ann Nutr Metab 2007, 51(4):331-334.
3. Lahjouji K., Mitchell G.A., Qureshi J.A. carnitine transport by organic cation transporters and systemic carnitine deficiency. Mol Gen Metab 2001, 73:287-297.
4. Wilcken B., Wiley V., Sim K.G., Carpentier K. Carnitine transporter defect diagnosed by newborn screening with electrospray tandem mass spectrometry. J Pediatr 2001, 138:581-584.
5. Koizumi A., Nozaki J., Ohura T., Kayo T., Wada Y., Nezu J., et al. Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigr ees with primary systemic carnitine deficiency. Hum Mol Genet 1999, 8:2247-2254.
6. Kinali M., Olpin S.E., Clayton P.T., Daubeney P.E.F., Mercuri E., Manzur A.Y., et al. Diagnostic difficulties in a case of primary systemic carnitine deficiency with idiopathic dilated cardiomyopathy. Eur J Paediatr Neurol 2004, 8:217-219.
7. Longo N., Amat di Sanfilipo, Pasquali M. Disorders of carnitine transport and the carnitine cycle. Am J Med Genet C Semin Med Genet 2006, 142:77-85.
8. Lamhonwah A.M., Olpin S.E., Pollitt R.J., Vianey-Saban C., Divry P., Guffon N., Novel OCTN2 mutations: no genotype-phenotype correlations: early carnitine therapy prevents cardiomyopathy, et al. Am J Med Genet 2002, 111(3):271-284.
9. Stanley C.A. Carnitine deficiency disorders in children. Ann N Y Acad Sci 2004, 1033:42-51.
10. Boles R.G., Buck E.A., Blitzer M.G., et al. Retrospective biochemical screening of fatty acid oxidation disorders in postmortem livers of life. J Pediatr 1998, 132:924-933.
11. Xiaofei E., Wada Y., Dakeishi M., Hirasawa F., Murata K., Masuda H., et al. Age-associated cardiomyopathy in heterozygous carrier mice of a pathological mutation of carnitine transporter gene, OCTN2. J Gerontol A Biol Sci Med Sci 2002, 57:B270-B278.
12. Takahashi R., Asai T., Murakami H., Murakami R., Tsuzuki M., Numaguchi Y. et al. Pressure overload -induced cardiomyopathy in heterozygous carrier mice of carnitine transporter gene mutation. Hypertension 2007, 50:497-502.